{
    "clinical_study": {
        "@rank": "154871", 
        "arm_group": {
            "arm_group_label": "CG-100 device", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to evaluate the CG-100 device, a single use, temporary\n      intraluminal bypass device,intended to reduce contact of fecal content with an anastomotic\n      site, following colorectal surgery (open or laparoscopic)."
        }, 
        "brief_title": "Safety, Tolerability and Performance Profile of the Cologuard Device CG-100 in Patients Undergoing Colorectal Surgery", 
        "condition": "Gastrointestinal Anastomosis", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  The patient is scheduled to undergo an elective colorectal surgery (open or\n             laparoscopic) which will require the creation of an anastomosis, maximally 20 cm\n             proximal from the anal verge\n\n          -  The patient is willing to comply with protocol-specified follow-up evaluations\n\n          -  The patient signed Informed Consent\n\n        Exclusion Criteria:\n\n          -  Pregnant or nursing female subjects\n\n          -  Patient surgical treatment is acute (not elective)\n\n          -  Patient has infections at the time of intervention\n\n          -  Major surgical or interventional procedures within 30 days prior to this study or\n             planned surgical or interventional procedures within 30 days of entry into this study\n\n          -  Patients with ASA (American Society of Anesthesiologists) classification > 3\n\n          -  diagnosis of bowel obstruction, bowel strangulation, peritonitis, bowel perforation,\n             local or systemic infection, ischemic bowel, carcinomatosis or extensively spread\n             inflammatory bowel disease\n\n          -  Patient is participating in another clinical trial within 30 days of screening\n\n          -  Patient has been taking regular steroid medication in the last 6 months\n\n          -  Contraindications to general anesthesia\n\n          -  Patient has preexisting sphincter problems or evidence of extensive local disease in\n             the pelvis\n\n          -  Internal diameter lumen of the colon is smaller than 25 mm or larger than 34 mm\n\n          -  Blood loss (> 500 cc)\n\n          -  Leak test failure during surgery\n\n          -  Any condition or surgical incidence where the device deployment can jeopardize the\n             patient's safety or interferes with study outcome per the discretion of the\n             investigator"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 8, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02109991", 
            "org_study_id": "CLD-001"
        }, 
        "intervention": {
            "arm_group_label": "CG-100 device", 
            "description": "Colorectal surgery performed per standard of care with deployment of the CG-100 device in the anastomosis site", 
            "intervention_name": "CG-100 device", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "April 8, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Kurt Van Der Speeten, Prof.", 
                    "phone": "+32-8-932-6524"
                }, 
                "facility": {
                    "address": {
                        "city": "Genk", 
                        "country": "Belgium", 
                        "zip": "3600"
                    }, 
                    "name": "Ziekenhuis Oost-Limburg"
                }, 
                "investigator": {
                    "last_name": "Kurt Van Der Speeten, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "toth.l@oncol.hu", 
                    "last_name": "L\u00e1szl\u00f3 T\u00f3th, Prof.", 
                    "phone": "+36122486008250"
                }, 
                "facility": {
                    "address": {
                        "city": "Budapest", 
                        "country": "Hungary", 
                        "zip": "H-112"
                    }, 
                    "name": "National Institute of Oncology"
                }, 
                "investigator": {
                    "last_name": "L\u00e1szl\u00f3 T\u00f3th, Prof.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "email": "nirw@clalit.org.il", 
                    "last_name": "Nir Wasserberg, Dr.", 
                    "phone": "+972-3-9376207"
                }, 
                "facility": {
                    "address": {
                        "city": "Petah Tikva", 
                        "country": "Israel", 
                        "zip": "49100"
                    }, 
                    "name": "Rabin Medical Center"
                }, 
                "investigator": {
                    "last_name": "Nir Wasserberg, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Hungary", 
                "Israel"
            ]
        }, 
        "number_of_arms": "1", 
        "official_title": "A Prospective, Multi-center, Single-arm, Open-label Study Designed to Evaluate Safety, Tolerability and Performance Profile of the Cologuard Device CG-100 in Patients Undergoing Colorectal Surgery", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Belgium: Federal Agency for Medicines and Health Products, FAMHP"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Rate of adverse events, and device related complications", 
            "safety_issue": "Yes", 
            "time_frame": "During surgical procedure and up to 30 days (+/- 5)"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02109991"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Occurrence of anastomotic leakage when the CG-100 is used", 
                "safety_issue": "No", 
                "time_frame": "Up until device removal day (10 days +/-1)"
            }, 
            {
                "measure": "Position of the device (internal sheath)", 
                "safety_issue": "No", 
                "time_frame": "Device removal day (10 days +/-1)"
            }, 
            {
                "measure": "Assessment of the device's application technique ease of placement and extraction of the device performance", 
                "safety_issue": "No", 
                "time_frame": "Device removal day (10 days +/-1)"
            }, 
            {
                "measure": "Determine subject tolerability of the device", 
                "safety_issue": "No", 
                "time_frame": "Device removal day (10 days +/- 1)"
            }
        ], 
        "source": "Cologuard Ltd.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Cologuard Ltd.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}